Drug · DIN 02367548
NTP-ACYCLOVIR
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since August 6, 2015.
- Drug Identification Number (DIN)
- 02367548
- Company (DIN owner)
- Teva Canada LimitedToronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Acyclovir J05AB01
- Class
- Human
- Record last updated
- June 22, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ACYCLOVIR | 800 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- July 5, 2013: NOC 14534Abbreviated New Drug Submission (ANDS) · Administrative merger/buyout
- August 3, 2011: NOC 12528Abbreviated New Drug Submission (ANDS) · New Manufacturer and Product Name
Other DINs named NTP-ACYCLOVIR
- DIN 02367513 · Cancelled Pre Market
- DIN 02367521 · Cancelled Pre Market